## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w
“Rebound” phenomenon of hepatitis C viremia after interferon therapy in “relapsed” patients with chronic hepatitis C
✍ Scribed by Hiroshi Hanada; Keisuke Hino; Kaori Fujii; Muneko Okazaki; Kiwamu Okita
- Publisher
- Springer Japan
- Year
- 1995
- Tongue
- English
- Weight
- 407 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The aim of this study was to elucidate the reduction of hepatocarcinogenesis by prolonged interferon (IFN) monotherapy in aged chronic hepatitis C patients. Inclusion criteria were biopsy‐proven chronic hepatitis or liver cirrhosis, 60 years and over, elevated serum aminotransferase and
## Abstract Studies were undertaken to investigate whether interferon therapy could induce hepatitis C virus (HCV) carriage with normal serum alanine aminotransferase (ALT) values using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 53 patients